LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

Search

Champions Oncology Inc

Отворен

СекторЗдравеопазване

6.17 -0.96

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

5.8100000000000005

Максимум

6.31

Ключови измерители

By Trading Economics

Приходи

-514K

-278K

Продажби

1.5M

17M

P/E

Средно за сектора

35.118

49.712

EPS

-0.02

Марж на печалбата

-1.679

Служители

213

EBITDA

-508K

104K

Дивиденти

By Acuity

Следващи печалби

22.07.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

5.1M

88M

Предишно отваряне

7.13

Предишно затваряне

6.17

Настроения в новините

By Acuity

100%

0%

315 / 342 Класиране в Healthcare

Champions Oncology Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Относно Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat